4 results
Approved WMOCompleted
To estimate the bleeding risk with rivaroxaban, compared with ASA, in addition to a singleantiplatelet agent (clopidogrel or ticagrelor), in subjects with a recent ACS .
Approved WMOWill not start
The main objective of this trial is to investigate the efficacy of inhaled molgramostim compared to placebo.
Approved WMOCompleted
The main objective of Study M15-722 is to characterize the efficacy, safety, and tolerability of ravagalimab (ABBV-323) as induction treatment in subjects with moderately to severely active UC.
Approved WMOCompleted
The main objective of this trial is to investigate safety of long term use of inhaled molgramostim by collecting information on the side effects.